Description
A ceramidase inhibitor; induces cell death in SW403 colon adenocarcinoma cells in a time- and concentration-dependent manner; increases intracellular ceramide accumulation and cytochrome C release and induces apoptosis in SW403 cells; reduces tumor growth and the number of hepatic metastases in SW403 and LoVo colon cancer mouse xenograft models at 75 mg/kg
Formal name: N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-tetradecanamide
Synonyms: (1R,2R)-B13|CAY10466
Molecular weight: 422.6
CAS: 35922-06-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Sphingolipid Turnover||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Lipid Biochemistry|Sphingolipids